1-10 of 10
Peter Brown
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma

Leo Meriranta, Amjad Alkodsi, Annika Pasanen, Maija Lepistö, Parisa Mapar, Yngvild Nuvin Blaker, Judit Jørgensen, Marja-Liisa Karjalainen-Lindsberg, Idun Fiskvik, Lars Tore G. Mikalsen, Matias Autio, Magnus Björkholm, Mats Jerkeman, Øystein Fluge, Peter Brown, Sirkku Jyrkkiö, Harald Holte, Esa Pitkänen, Pekka Ellonen, Sirpa Leppä
Journal: Blood
Blood (2022) 139 (12): 1863–1877.
https://doi.org/10.1182/blood.2021012852
Published: 2022
Includes: Supplemental data
Journal Articles

TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy

Clinical Trials & Observations
Christian W. Eskelund, Christina Dahl, Jakob W. Hansen, Maj Westman, Arne Kolstad, Lone B. Pedersen, Carmen P. Montano-Almendras, Simon Husby, Catja Freiburghaus, Sara Ek, Anja Pedersen, Carsten Niemann, Riikka Räty, Peter Brown, Christian H. Geisler, Mette K. Andersen, Per Guldberg, Mats Jerkeman, Kirsten Grønbæk
Journal: Blood
Blood (2017) 130 (17): 1903–1910.
https://doi.org/10.1182/blood-2017-04-779736
Published: 2017
Includes: Supplemental data
Journal Articles

Safety, Efficacy, and Determination of the Recommended Phase 2 Dose for the Oral Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330)

Christine Chen, MD, Ramiro Garzon, MD, Martin Gutierrez, Meagan A. Jacoby, MD PhD, Peter Brown, Ian Flinn, Richard M. Stone, MD, Mary Lynn Savoie, MD, Rachid Baz, Nashat Y. Gabrail, MD, Michael Wang, MD, Peter Martin, MD, David Siegel, MD PhD, Morten Mau-Sørensen, Michael Andreef, Tracey Marshall, Jean-Richard Saint-Martin, Robert Carlson, Sharon Shacham, Michael Kauffman, John Kuruvilla, MD
Journal: Blood
Blood (2015) 126 (23): 258.
https://doi.org/10.1182/blood.V126.23.258.258
Published: 2015
Journal Articles

miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator

Simon Husby, Ulrik Ralfkiaer, Christian Garde, Roza Zandi, Sara Ek, Arne Kolstad, Mats Jerkeman, Anna Laurell, Riikka Räty, Lone B. Pedersen, Anja Pedersen, Mats Ehinger, Christer Sundström, Marja-Liisa Karjalainen-Lindsberg, Jan Delabie, Erik Clasen-Linde, Peter Brown, Jack B. Cowland, Christopher T. Workman, Christian H. Geisler, Kirsten Grønbæk
Journal: Blood
Blood (2015) 125 (17): 2669–2677.
https://doi.org/10.1182/blood-2014-06-584193
Published: 2015
Includes: Supplemental data
Journal Articles

Results of a Phase II Study with Bendamustine and Ofatumumab in Untreated Indolent B-Cell Non-Hodgkin's Lymphoma

Nathan H. Fowler, MD, Stephen P. Kahanic, MD, Andres Forero, MD, Mihaela C. Munteanu, MS, Glen L. Davis, MS, Peter Brown, DPhil, Eric Van Den Neste, MD, Fritz C. Offner, MD, PhD, Dominique Bron, MD, Myron S. Czuczman, MD
Journal: Blood
Blood (2011) 118 (21): 778.
https://doi.org/10.1182/blood.V118.21.778.778
Published: 2011
Journal Articles

The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)

Brief Report
Christian H. Geisler, Arne Kolstad, Anna Laurell, Riikka Räty, Mats Jerkeman, Mikael Eriksson, Marie Nordström, Eva Kimby, Anne Marie Boesen, Herman Nilsson-Ehle, Outi Kuittinen, Grete F. Lauritzsen, Elisabeth Ralfkiær, Mats Ehinger, Christer Sundström, Jan Delabie, Marja-Liisa Karjalainen-Lindsberg, Peter Brown, Erkki Elonen, for the Nordic Lymphoma Group
Journal: Blood
Blood (2010) 115 (8): 1530–1533.
https://doi.org/10.1182/blood-2009-08-236570
Published: 2010
Includes: Supplemental data
Journal Articles

Assessment of Targeted Systemic Exposure Based on Ex-Vivo Concentrations of Bendamustine and Chlorambucil and Related Clinical Outcomes

Mona Darwish, PhD, Peter Brown, DPhil, Debra M Bensen-Kennedy, MD, Lauren Young
Journal: Blood
Blood (2008) 112 (11): 4211.
https://doi.org/10.1182/blood.V112.11.4211.4211
Published: 2008
Journal Articles

Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

Clinical Trials & Observations
Christian H. Geisler, Arne Kolstad, Anna Laurell, Niels S. Andersen, Lone B. Pedersen, Mats Jerkeman, Mikael Eriksson, Marie Nordström, Eva Kimby, Anne Marie Boesen, Outi Kuittinen, Grete F. Lauritzsen, Herman Nilsson-Ehle, Elisabeth Ralfkiær, Måns Åkerman, Mats Ehinger, Christer Sundström, Ruth Langholm, Jan Delabie, Marja-Liisa Karjalainen-Lindsberg, Peter Brown, Erkki Elonen, for the Nordic Lymphoma Group
Journal: Blood
Blood (2008) 112 (7): 2687–2693.
https://doi.org/10.1182/blood-2008-03-147025
Published: 2008
Journal Articles

Mantle Cell Lymphoma Can Be Cured by Intensive Immunochemotherapy with In-Vivo Purged Stem-Cell Support; Final Report of the Nordic Lymphoma Group MCL2 Study.

Christian H. Geisler, MD, PhD, Erkki Elonen, MD, PhD, Arne Kolstad, MD, PhD, Anna Laurell, MD, PhD, Niels Andersen, MD, PhD, Lone B. Pedersen, B.Sc, Anne Marie Boesen, MD, Phd, Mikael Eriksson, MD, PhD, Mats Jerkeman, MD, PhD, Eva Kimby, MD, PhD, Outi Kuittinen, MD, PhD, Grethe F. Lauritzen, MD, PhD, Herman Nilsson-Ehle, MD, PhD, Marie Nordström, MD, PhD, Elisabeth Ralfkiaer, MD, PhD, Måns Åkerman, MD, PhD, Mats Ehinger, MD, PhD, Christer Sundström, MD, PhD, Ruth Langholm, MD, PhD, Jan Delabie, MD, PhD, Marja-Liisa Karjalainen-Lindsberg, MD, PhD, Peter Brown, MD, PhD
Journal: Blood
Blood (2007) 110 (11): LB1.
https://doi.org/10.1182/blood.V110.11.LB1.lb1
Published: 2007
Journal Articles

A Randomized, Open-Label Study of Lestaurtinib (CEP-701), an Oral FLT3 Inhibitor, Administered in Sequence with Chemotherapy in Patients with Relapsed AML Harboring FLT3 Activating Mutations: Clinical Response Correlates with Successful FLT3 Inhibition.

Mark Levis, MD, PhD, B. Douglas Smith, MD, Miloslav Beran, MD, Maria R. Baer, MD, Harry P. Erba, MD, Larry Cripe, MD, Steven Coutre, MD, Anjali Advani, MD, Alexander Perl, MD, Marcel Devetten, MD, Robert Stuart, MD, Martin S. Tallman, MD, Peter Brown, PhD, Lothar Tremmel, Donald Small, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 403.
https://doi.org/10.1182/blood.V106.11.403.403
Published: 2005